People
It’s fascinating to see things moving in an entirely new direction thanks to the work of these seven millennial biotech influencers.
LNC Therapeutics, a French biotech company specializing in gut microbiome-based drug research and discovery, announced formation of its Scientific Advisory Board, composed of preeminent experts in the gut microbiome and related therapeutic applications.
Biopharma leader with deep oncology product launch experience will spearhead global commercial strategy and execution for ADCT-402
Nosopharm, a company dedicated to the research and development of new anti-infective drugs, announces changes to its supervisory board: Jacques Biton has been appointed as chairman, taking over from Gilles Alberici, while Frédéric Hammel joins the board as a member, representing Elaia Partners.
The Annual General Meeting of BioArctic AB on May 9, 2019, adopted instructions regarding the appointment of the Nomination Committee.
Santhera Pharmaceuticals announces a strategic change to its management team with the appointment of Dario Eklund as CEO, effective December 1, 2019.
Lifescience Dynamics, an award-winning global decision support consultancy serving the life sciences sector for over 15 years, has appointed Alfred Reszka, PhD to the newly created role of Chief Business Officer.
Zelluna Immunotherapy, the biotechnology company specialising in T-cell receptor based immunotherapies targeting a broad range of solid cancers with high unmet medical need, announces the appointment of Dr Bent Jakobsen to its board.
Bruce Morimoto joins Cerecin as Vice President of Drug Development
In the United States, an organization’s culture has been at the forefront of talent attraction and employee engagement initiatives for more than a decade.
PRESS RELEASES